• Progenics Enters Collaboration with Veterans Affairs for Medical Image Analysis
  • Breast, Ovarian Cancer Therapy Seen to Delay to Progression in Advanced Prostate Cancers in Phase 3 Trial
  • First Patients Dosed in Phase 2b Trial Testing Oral Docetaxel Treatment for Advanced Prostate Cancer
  • Prostate Cancer Therapy Zytiga Makes WHO’s Essential Medicines List
  • Xtandi Delays Disease Worsening in Metastatic Hormone-sensitive Prostate Cancer, Study Says
  • FDA Approves Nubeqa Tablets for Men with Non-metastatic Castration-resistant Prostate Cancer
  • Invitae Offers Free Genetic Testing, Counseling for Hereditary Prostate Cancer
  • ADT Linked to Higher Alzheimer’s and Dementia Risk in Older Prostate Cancer Patients, Study Suggests
  • PyL Imaging Agent Ably Detects Lesions Outside the Prostate, Phase 2/3 Trial Shows
  • Video Series Tackles Prostate Cancer and ADT Use in Doctor-Patient Format
  • MSN Labs to Launch Generic Version of Zytiga in U.S. Following FDA Approval
  • Liquid Biopsy Could Help Identify Aggressive Prostate Cancers, Study Says